Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MModal is a healthcare technology company focused on clinical documentation, medical speech recognition, natural language understanding, computer-assisted physician documentation, and coding workflow software for healthcare providers. Historically, the company combined transcription services with AI-powered documentation tools used by hospitals, health systems, and clinicians. Its core products included the Fluency suite, such as Fluency Direct and related documentation improvement and coding solutions. MModal’s technology business was acquired by 3M in February 2019 for an enterprise value of $1 billion, and those assets later became part of Solventum following 3M’s April 1, 2024 health care spin-off. The M*Modal brand and product documentation remain in use within Solventum’s health information technology portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M*Modal.